Using Technology to Affect Influenza Vaccine Coverage Among Children With Chronic Respiratory Conditions.

Using Technology to Affect Influenza Vaccine Coverage Among Children With Chronic Respiratory Conditions.

J Pediatr Health Care. 2016 Jul 27;

Authors: Bay SL, Crawford DJ

Abstract
INTRODUCTION: Influenza presents additional burdens for children with chronic respiratory conditions. Influenza vaccinations may reduce complications, yet approximately half of children remain unprotected. Evidence supports integration of text and e-mail into multicomponent strategies to increase influenza vaccination rates among children with chronic respiratory conditions.
METHODS: A single text and e-mail message was sent to those with enabled preferences in the patient portal. A follow-up survey assessed aspects of message receipt. Surveys were completed without collection of demographics.
RESULTS: A total of 3,206 messages were successfully delivered. Surveys were initiated by 107 recipients. Frequency analysis showed that text and e-mail messages were preferred forms of communication. A statistically significant relationship was found between receiving a message and receiving an influenza vaccination (p = .027).
DISCUSSION: Text and e-mail messaging are cost effective and well received, and they can be easily integrated into existing systems. These methods are translatable across populations and can convey various types of messages.

PMID: 27475928 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil … – MarketWatch

Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil
MarketWatch
BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ — Decision Resources Group finds that the asthma market in Brazil and Mexico currently faces severe coverage restrictions. The uptake of several newly approved agents, the anticipated label extension of …
Asthma agents currently face a suboptimal coverage environment in Brazil and The Pharma Letter

all 4 news articles »

View full post on asthma – Google News

CDC Reports on Vaccine Coverage Among Patients with Asthma – Monthly Prescribing Reference


Dallas Morning News

CDC Reports on Vaccine Coverage Among Patients with Asthma
Monthly Prescribing Reference
Among Patients with Asthma. The CDC analyzed data from the 2010 and 2011 National Health Interview Survey to provide the first update of national vaccine coverage among noninstitutionalized patients with asthma since the new ACIP recommendations.
Too few Americans with asthma are getting flu shotsWDAM-TV

all 157 news articles »

View full post on asthma – Google News

Aerocrine: Positive reimbursement coverage continues for Aerocrine’s asthma test – The Herald | HeraldOnline.com

Aerocrine: Positive reimbursement coverage continues for Aerocrine's asthma test
The Herald | HeraldOnline.com
Specifically, FeNO testing is covered for the treatment of asthma when it is used in the diagnosis of allergic airway inflammation or when used in determining likelihood of steroid responsiveness in individuals with chronic symptoms suggestive of

View full post on asthma – Google News

Aerocrine: BlueCross BlueShield of Minnesota to begin FeNO Coverage in August – Business Wire (press release)

Aerocrine: BlueCross BlueShield of Minnesota to begin FeNO Coverage in August
Business Wire (press release)
Following the transition period, exhaled nitric oxide measurement (CPT code 95012) will be covered for patients with asthma. BlueCross BlueShield of Minnesota is the largest insurance company in the state and provides coverage to approximately 66

and more »

View full post on asthma – Google News

Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for … – Bradenton Herald

Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for
Bradenton Herald
"These coverage policies support the CMS payment decisions announced earlier this year and further confirm bronchial thermoplasty as a promising new advancement in the treatment of severe asthma." Bronchial thermoplasty delivered by the Alair System

View full post on asthma – Google News

Boston Scientific’s Alair Bronchial Thermoplasty System Receives Private Coverage – news Stories

Boston Scientific's Alair Bronchial Thermoplasty System Receives Private Coverage
news Stories
Minnesota-based HealthPartners and Michigan-based Priority Health recently issued the first public postings of positive insurance coverage policies providing their respective memberships with reimbursement for this procedure used to treat severe asthma
Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for MarketWatch (press release)

all 11 news articles »

View full post on asthma – Google News

Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for … – MarketWatch (press release)

Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for
MarketWatch (press release)
"These coverage policies support the CMS payment decisions announced earlier this year and further confirm bronchial thermoplasty as a promising new advancement in the treatment of severe asthma." Bronchial thermoplasty delivered by the Alair System

and more »

View full post on asthma – Google News

Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine’s FeNo Testing … – Business Wire (press release)

Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine's FeNo Testing
Business Wire (press release)
“FeNO testing is a significant advancement in managing the patient with asthma. Since the publication of the American Thoracic Guideline on FeNO, this test should be standard of care in every clinic managing asthma patients.
South Carolina adopts positive coverage of Aerocrine's FeNO testing in CisionWire (press release)

all 2 news articles »

View full post on asthma – Google News